BinaxNOW COVID-19 Antigen Self Test (2 Tests): A simple solution for COVID-19 infection detection, with rapid results in the convenience of your home. This test has received FDA Emergency Use Authorization for self-testing without the need to ship samples to a lab or for a prescription from your healthcare provider. This 15-minute test can be completed anytime, anywhere. This test does NOT meet the CDC testing requirements to enter the U.S.rapid antigen test home kit when returning from a trip abroad.
Get results in 15 minutes
Detects active COVID-19 infection
Includes illustrated step-by-step instructions
Perform simple test procedure using a minimally invasive nasal swab
Know your result now, without a need to wait for results from your healthcare provider
Simply test yourself twice within 3 days, with at least 36 hours between tests
Heres How the Test Works:
1. Prepare for the test
2. Collect nasal sample, or help others administer if they require assistance
3. Perform the test
4. See results after 15 minutes
5. Test again within three days (with at least 36 hours between tests)
Refer to product insert for full instructions.
We aim to show you accurate product information. Manufacturers, suppliers and others provide what you see here, and we have not verified it.See our disclaimer
System of Measurement: U.S. Customary
Flexible Spending Account-Eligible: Y
rapid antigen test home kit
Manufacturer: Abbott Diagnostics Scarborough Inc.
Price Per Unit UOM: Each
PPU Quantity of Units: 1 Each
This test does NOT meet the CDC testing requirements to enter the U.S rapid antigen test home kit . when returning from a trip abroad. The self-test is indicated for children as young as 2 years old when samples are collected by an adult, and for all people 15 and older. The BinaxNOW COVID-19 Antigen Self Test has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization. It has been authorized only for the detection of proteins from SARSCoV-2, not for any other viruses or pathogens, and are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner. BinaxNOW COVID-19 Antigen Self Test should be performed twice in 3 days, at least 36 hours apart. 2021 Abbott.